Generalized Anxiety Disorder (GAD) is a common mental health disorder characterized by persistent, excessive and unrealistic fear and worry about the multiple facets of life (family, health, finances, work or school) (Leonard & Abramovitch, 2019; Stein et al., 2021). GAD is frequently distributed worldwide, reaching an estimated lifetime prevalence of 3.7% in adults of the general population, with females having approximately twice as higher rates when compared to males (Yang et al., 2021). Additionally, in the primary care setting, GAD is the most common anxiety disorder contracted, having an approximate 8% prevalence (Sapra et al., 2020). A Finnish study specified that the repartition of GAD among primary care patients was 4.1% for males and 7.1% for females (Kujanpää et al., 2014).
GAD can present clinically as a generalized worry concomitant with nonspecific physical and psychological issues (DeMartini et al., 2019). There is also an intimate link between anxiety and other negative emotional states, particularly depression. While anxiety and depression have similar emotional profiles (Brady & Kendall, 1992; Clark & Watson, 1991), they are different in terms of several areas. Blumberg and Izard (1986) (Blumberg & Izard, 1986) pointed out that while fear and apprehension are dominant in anxiety, sadness and lack of energy are central features of depression. Adding to that, stress, particularly in early life, has been shown to exert a significant influence on risk of anxiety as well as further mental disorders (e.g. depression) (Bartlett et al., 2017; Slavich & Irwin, 2014). Additionally, patients with GAD may often present with somatic manifestations which can induce a diagnostic plight, resulting in a poor diagnosis of the disease (Health, 2011). For this reason, efforts have been put in order to set up a GAD scale, which is a screening test that may be used in primary care settings to help orient suspicions of GAD and reduce confounding differentials.
There exists a variety of scales used by clinicians to evaluate anxiety disorders; the most prominent ones include: Hamilton Anxiety Rating Scale (HAM-A) (Gunver et al., 2021), Beck Anxiety Inventory (BAI) (Oh et al., 2018), Penn State Worry Questionnaire (PSWQ) (Johnco et al., 2022), State-Trait Anxiety Inventory (STAI) (Knowles & Olatunji, 2020), and finally the widely used GAD scale with its three evolutionary faces (GAD-9, GAD-7, and GAD-5). Before detailing the series of the GAD scales, we would like to point out that of all those present scales, the GAD scale has shown to be the most effective and the most clinically-friendly screening test for GAD due to its brief, quick and precise structure (Dhira et al., 2021), which opposes the non-specific broader features and the lengthy set of items of the other tests.
GAD Scale
The GAD scale initially begun as nine items summarizing all of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnostic criteria for GAD, in addition to four items deduced from existing anxiety scales (Spitzer et al., 2006). Afterwards, a Generalized Anxiety Disorder-7 scale (GAD-7) is a seven-item model of the initial scale that appeared, and has demonstrated high sensitivity and specificity in both the general population and primary care patients (Moreno et al., 2019). Subsequently, the Generalized Anxiety Disorder-5 (GAD-5) scale is a five-item version which is directly correlated with the International Classification of Diseases (ICD-11) diagnostic guidelines for anxiety and depression, and was obtained from several studies of the primary care population (Goldberg et al., 2017). The simplicity and briefness of the GAD-5 scale provide it a favorable condition to be more potentially applied in the general population and in primary care settings than the GAD-7 and the GAD-9 scales (Goldberg et al., 2017).
Consequently, a unique validation study conducted in Mexico conveyed the unidimensional structure as well as the reliability of the GAD-5 scale and noted the presence of configural and metric invariance in the comparison by sex, age, and educational level, as well as scalar invariance in the comparison by sex and age (Astudillo-García et al., 2022). To our knowledge, the validation of the GAD-5 scale and measurement of its parameters’ invariances has only been done across the Mexican population. Validating the invariance of parameters across ages, educational levels and sexes aids in understanding whether the five measures of the GAD-5 scale are equivalent throughout different socio-demographic groups (Astudillo-García et al., 2022). Hence, since the Arabic version of the GAD-5 addresses a major linguistic barrier in psychological research, its validation is highly significant.
The present study
In Lebanon, a study done in 2009 proved that Lebanon expressed a 12 months rate of 11.2% for any anxiety disorder (Tanios et al., 2009). Despite the lack of recent data and numbers, it is theoretically assumed that anxiety disorders are currently more routinely encountered in the Lebanese population especially after the year 2019 which was a hallmark that historically altered the life of the Lebanese citizens due to successive events such as COVID-19, the long-lasting economic crisis, as well as the Beirut explosion which had detrimental outcomes on the general population (Hashim et al., 2022); however, no research was done to solely evaluate GAD in Lebanon using the GAD-5 scale, presumably due to the unavailability of an Arabic language-validated scale. Therefore, this study's goal was to investigate the psychometric qualities of an Arabic translation of the GAD-5 in a group of adult’s Lebanese participants. The Arabic GAD-5 is expected to: (1) replicate the one factor structure that was first proposed; (2) exhibit strong composite validity and invariance of measurements by gender (males vs. females), age and educational level; and (3) show sufficient patterns of correlations with depression and stress.